{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:01:42Z","timestamp":1648684902334},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.cancergencyto.2006.09.005","type":"journal-article","created":{"date-parts":[[2007,1,8]],"date-time":"2007-01-08T12:04:02Z","timestamp":1168257842000},"page":"158-164","source":"Crossref","is-referenced-by-count":2,"title":["Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma"],"prefix":"10.1016","volume":"172","author":[{"given":"Malini","family":"Sathanoori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Shekhter-Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley M.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven H.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2006.09.005_bib1","series-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours","first-page":"168","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2001"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib2","first-page":"241","article-title":"Chromosome 11 translocation breakpoints at the PRAD1\/cyclin D1 gene locus in centrocytic lymphoma","volume":"7","author":"Williams","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/10428199609067577","article-title":"PRAD1\/Cyclin D1 gene overexpression in mantle cell lymphoma","volume":"21","author":"Oka","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib4","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V83.7.1871.1871","article-title":"Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas","volume":"83","author":"Rimokh","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1615\/CritRevOncog.v7.i3-4.30","article-title":"Implication of cyclin D1 in malignant lymphoma","volume":"7","author":"Callanan","year":"1996","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2141.2003.04761.x","article-title":"Molecular basis of mantle cell lymphoma","volume":"124","author":"Bertoni","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/hupa.2002.30221","article-title":"From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades","volume":"33","author":"Swerdlow","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib8","first-page":"115","article-title":"Mantle-cell lymphoma","volume":"36","author":"Campo","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib9","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood.V93.4.1372","article-title":"Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features","volume":"93","author":"Cuneo","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib10","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood.V87.4.1512.bloodjournal8741512","article-title":"Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization","volume":"87","author":"Coignet","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cancergencyto.2004.02.002","article-title":"Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region","volume":"154","author":"Maravelaki","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cancergencyto.2005.08.012","article-title":"Molecular cytogenetic analysis of leukemic mantle cell lymphoma with a cryptic t(11;14)","volume":"165","author":"Aamot","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V88.2.674.bloodjournal882674","article-title":"Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines","volume":"88","author":"Chesi","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib15","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jcp.56.10.798","article-title":"Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14","volume":"56","author":"Aventin","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1097-2765(00)80180-X","article-title":"Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell","volume":"3","author":"Gabrea","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib17","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","article-title":"PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma","volume":"84","author":"Bosch","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1309\/BDR959TT4JU6388C","article-title":"Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival","volume":"125","author":"Cook","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-4608(91)90148-N","article-title":"Atypical (7;19) translocation in acute myelomonocytic leukemia","volume":"57","author":"Sherer","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib20","article-title":"ISCN 2005: an international system for human cytogenetic nomenclature (2005)","year":"2005"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib21","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood.V83.12.3689.3689","article-title":"Rearrangement of CCND1 (BCL1\/PRAD1) 3\u2032 untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias","volume":"83","author":"Rimokh","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/10428190290016890","article-title":"Cytogenetic analysis in mantle cell lymphoma: a review of 214 cases","volume":"43","author":"Au","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib23","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","article-title":"p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas","volume":"87","author":"Hernandez","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib24","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood.V90.10.4078","article-title":"Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma","volume":"90","author":"Koduru","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.09.005_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0165-4608(98)00228-3","article-title":"Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma","volume":"111","author":"Espinet","year":"1999","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460806006078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460806006078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T17:06:32Z","timestamp":1587315992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460806006078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0165460806006078"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2006.09.005","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}